找化学品上960化工网!
960化工网

那格列奈 | 105816-04-4

那格列奈
Nateglinide
105816-04-4
C19H27NO3
317.4226
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:那格列奈结构式
5311309
那格列奈价格
简介
Nateglinide 是 D-苯丙氨酸的一个衍生物,是一种具有口服活性的、短效的促胰岛素释放化合物,也是 DPP IV 的抑制剂。 Nateglinide 抑制胰岛 β 细胞中 ATP 敏感的 K+ 通道。Nateglinide 可用于 2 型糖尿病 (非胰岛素依赖的) 的研究。
名称和标识符
MDL MFCD00875706
InChIKey OELFLUMRDSZNSF-OFLPRAFFSA-N
Inchi 1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1
SMILES O=C(C1([H])C([H])([H])C([H])([H])C([H])(C([H])(C([H])([H])[H])C([H])([H])[H])C([H])([H])C1([H])[H])N([H])[C@@]([H])(C(=O)O[H])C([H])([H])C1C([H])=C([H])C([H])=C([H])C=1[H]
别名信息
- 中文别名 -
  • 那格列奈
  • [2-(2,6-二氯苯基)亚氨基]咪唑烷盐酸盐
  • 110降压片
  • 催压降
  • 可乐亭
  • 血压得平
  • 压泰生
  • 盐酸可乐宁
  • 那格列奈 GMP
  • 那格列萘
  • (-)-N-(反-4-异丙基环己基羰基)-
  • 6-O-α-麦芽糖基-α-环糊精
  • Nateglinide 那格列奈
  • 法莫替丁相关化合物A盐酸盐
  • 那格列奈 EP标准品
  • 那格列奈 USP标准品
  • 那格列奈 标准品
  • 那格列奈-D5
  • 那格列奈标准品(JP)
  • 那格列奈那格列奈
  • N-(反式-4-异丙基环己基甲酰)-D-苯丙氨酸
  • 氘代那格列奈-d5
  • N-[(反-4-异丙基环己基)羰基]-D-苯丙氨酸
  • 那格列奈主要中间体
  • 那格列奈(H晶型)
  • 那格列奈溶液,100PPM
  • 那格列萘, 一种胰岛素促分泌剂
  • (-)-N-(反-4-异丙基环已基羰基)-D-苯丙氨酸
  • 那格列奈标准品
- 英文别名 -
  • Nateglinide
  • N-(trans-4-Isopropylcylcohexylcarbonyl)-D-phenylalanine
  • N-[[TRANS-4-(1-METHYLETHYL)CYCLOHEXYL]CARBONYL]-D-PHENYLALANINE
  • A4166
  • A-4166
  • ay4166
  • DJN 608
  • Fastic
  • Fastic-d5
  • Glinate
  • N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine
  • Natelide
  • Senaglinide
  • STARLIX
  • Starlix DS
  • Starsis
  • 3-Phenyl-2-(4-propan-2-ylcyclohexyl)carbonylamino-propanoic acid
  • Trazec
  • Nateglinide [INN]
  • AY 4166
  • A 4166
  • SDZ DJN 608
  • 41X3PWK4O2
  • (-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine
  • N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine
  • (2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
  • N-[(trans-4-isopropylcyclohexyl)carbonyl]-D-phenylalanine
  • Starlix
  • 105816-04-4
  • 105746-37-0
  • CHEBI:94617
  • HY-B0422
  • (2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic acid
  • 105816-06-6
  • SW197528-2
  • nateglinide
  • D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-
  • nateglinida
  • UNII-XTM4DQP5S5
  • MFCD00875706
  • Z1514053266
  • EN300-27126236
  • (2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic acid
  • Nateglinide
  • (r)-2-((1r,4r)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid
  • SCHEMBL22088
  • Starsis (TN)
  • ((1r,4R)-4-isopropylcyclohexane-1-carbonyl)-D-phenylalanine
  • n-(trans-4-Isopropylcylolohexylcarboxyl)-d-phenylpropylicacid
  • D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, cis-
  • SMR000466372
  • UNII-41X3PWK4O2
  • CCG-100898
  • 2-[(4-Isopropyl-cyclohexanecarbonyl)-amino]-3-phenyl-propionic acid
  • N-[[cis-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine(Nateglinide Impurity)
  • N-((cis-4-Isopropylcyclohexyl)carbonyl)-D-phenylalanine
  • n-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine
  • Tox21_111432
  • AB00639979-06
  • NATEGLINIDE [EP MONOGRAPH]
  • GTPL6833
  • Nateglinide, United States Pharmacopeia (USP) Reference Standard
  • NATEGLINIDE [USP MONOGRAPH]
  • AY4166
  • SCHEMBL303827
  • AB00639979-11
  • HMS2051G20
  • AB00639979-08
  • AKOS005577723
  • N-((cis-4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine
  • AKOS015841612
  • DJN-608
  • NATEGLINIDE [ORANGE BOOK]
  • N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine
  • NCGC00178741-03
  • Nateglinide (Starlix)
  • CHEMBL783
  • (2R)-3-phenyl-2-{[4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
  • A801324
  • Nateglinide cis Impurity
  • Nateglinide impurity C
  • SCHEMBL13753829
  • D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-
  • EN300-303645
  • nateglinidum
  • Nateglinide, Starlix
  • NCGC00271534-02
  • MLS006011429
  • Nateglinide [USAN:USP:INN:BAN]
  • Q-201449
  • NATEGLINIDE [VANDF]
  • Nateglinide, >=98% (HPLC), solid
  • Q2254797
  • CHEMBL2114389
  • carboxamido)-3-phenylpropanoic acid
  • AY-4166
  • Tox21_111432_1
  • KS-5143
  • NS00073312
  • s2489
  • (R)-2-rel-((1r,4R)-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoicacid
  • A1-02996
  • D-Nateglinide
  • AB00639979-09
  • YM-026
  • D01111
  • DTXCID7020687
  • OELFLUMRDSZNSF-BRWVUGGUSA-N
  • (2R)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
  • AKOS015960899
  • {N}-[({TRANS}-4-ISOPROPYLCYCLOHEXYL)CARBONYL]-D-PHENYLALANINE
  • NATEGLINIDE [MI]
  • NCGC00271534-03
  • DTXSID9040687
  • NATEGLINIDE [USP-RS]
  • trans-N-{[4-(1-methylethyl)cyclohexyl]carbonyl}-D-phenylalanine
  • senaglinide
  • BCP28400
  • NSC 758695
  • NATEGLINIDE [WHO-DD]
  • CHEBI:31897
  • BDBM50344967
  • Nateglinide, European Pharmacopoeia (EP) Reference Standard
  • (trans-4-isopropylcyclohexane-1-carbonyl)-D-phenylalanine
  • N-(Trans-4-Isopropylcyclohexylcarbonyl)-D-Phenyl Alanine
  • trans-N-((4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine
  • (R)-2-rel-((1r,4R)-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid
  • Nateglinide impurity C [EP]
  • XTM4DQP5S5
  • Nateglinide (JP17/USP/INN)
  • D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-
  • AC-1690
  • NATEGLINIDE [JAN]
  • AB00639979_12
  • HMS2235O08
  • (2R)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid
  • NATEGLINIDE [MART.]
  • (R)-2-((1r,4R)-4-isopropylcyclohexane
  • NATEGLINIDE IMPURITY C [EP IMPURITY]
  • NSC-758695
  • n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
  • NATEGLINIDE CIS-ISOMER [USP IMPURITY]
  • BIDD:GT0257
  • NATEGLINIDE [USAN]
  • NS00000602
  • Nateglinide cis-isomer [USP]
  • Q27166439
  • MLS000759500
  • SCHEMBL9232138
  • D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, trans-
  • NATEGLINIDE [EMA EPAR]
  • MLS003915639
  • DB00731
  • SCHEMBL7880361
  • NC00148
  • N0912
  • SDZ-DJN-608
  • D-Phenylalanine, N-((cis-4-(1-methylethyl)cyclohexyl)carbonyl)-
  • MLS001424043
  • CAS-105816-04-4
  • HMS3715F12
  • HMS2089A10
  • HMS3675G17
  • NCGC00095121-01
  • SDZ-DJN 608
物化性质
实验特性
LogP 3.65180
PSA 66.40000
Merck 6428
折射率 1.536
沸点 527.6 °C at 760 mmHg
熔点 137-141 ºC
闪点 272.9 °C
溶解度 DMSO: >5mg/mL
颜色与性状 白色结晶粉末
比旋光度 -9.4° (c=1,in methanol)
密度 1.104
计算特性
精确分子量 317.19900
氢键供体数量 2
氢键受体数量 3
可旋转化学键数量 6
同位素质量 317.199094
重原子数量 23
复杂度 393
同位素原子数量 0
确定原子立构中心数量 1
不确定原子立构中心数量 0
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 3.2
拓扑分子极性表面积 66.4
海关数据
海关编码 2924299090
海关数据

中国海关编码:

2924299090

概述:

2924299090. 其他环酰胺(包括环氨基甲酸酯)(包括其衍生物以及他们的盐). 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:30.0%

申报要素:

品名, 成分含量, 用途, 包装

Summary:

2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

生产方法和用途
用途 降糖药物。
相关文献
专业数据库参考
PubChemId 5311309
参考资料
Reaxys RN 6486870
Beilstein MFCD00875706
960化工网为您提供那格列奈专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:105816-04-4,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等
平台客服 平台客服

平台在线客服